Dr. Nielsen on the Pros and Cons of the Ki67 Assay in Breast Cancer

onclivetv has 407 videos Subscribe Here

Description: Torsten O. Nielsen, MD, PhD, FRCPC, a professor of pathology at the University of British Columbia, discusses the pros and cons of using the Ki67 as a prognostic marker in breast cancer.
Shared By : onclivetv
Posted on : 09/27/13
Added : 4 years ago
Category : Breast Cancer

More From onclivetv

Nothing found.